跳至主要内容
临床试验/NCT03718988
NCT03718988已完成不适用

SWAP-MEAT: Study With Appetizing Plant Food - Meat Eating Alternatives Trial

Stanford University2 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2019年1月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
38
试验地点
2
主要终点
Trimethylamine N-oxide (TMAO).

研究概览

简要总结

This study aims to investigate the impact of replacing meat consumption with plant-based meat alternative consumption on cardiovascular health, the gut microbiome, and metabolic status.

详细描述

Plant-based meat alternatives that closely emulate animal protein provide a new opportunity to decrease meat consumption worldwide. Decreasing meat consumption and shifting to a plant-based diet has been linked to improvements in physical health, including decreased risk of cardiovascular disease, metabolic syndrome, and type 2 diabetes (Kahleova, Levin, & Barnard, 2017). However, the extent to which plant-based meat alternatives specifically can modulate biomarkers of physical health, particularly TMAO and IGF-1, and the gut microbiome remain relatively unexplored. It is also largely unknown to what extent consumers can feasibly and sustainably exchange meat products for plant-based meat alternatives for extended periods of time. Plant-based meat alternatives offer a promising way to support consumers' shift to a plant-based diet, and in turn, to potentially improve levels of TMAO and IGF-1 and decrease cardiovascular risk. Thus, the investigators hypothesize that consumer levels of TMAO and IGF-1 will be improved after 8 weeks of consuming plant-based meat alternative products, as compared to 8 weeks of consuming traditional meat products.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Meat consumption (beef, pork/sausage, chicken) on average ≥ once a day
  • Willing to consume meat (beef, pork/sausage, chicken) ≥ 2 times a day

排除标准

  • Weight < 110 lb
  • LDL-C >190 mg/dL
  • Systolic blood pressure (SBP) > 160 mmHg OR Diastolic blood pressure (DBP) > 90 mmHg
  • Use of any of the following drugs/supplements within the last 2 months:
  • systemic antibiotics, antifungals, antivirals or antiparasitics (intravenous, intramuscular, or oral);
  • corticosteroids (intravenous, intramuscular, oral, nasal or inhaled);
  • cytokines;
  • methotrexate or immunosuppressive cytotoxic agents;
  • Chronic, clinically significant, or unstable (unresolved, requiring on-going changes to medical management or medication) pulmonary, cardiovascular, gastrointestinal, hepatic or renal functional abnormality, as determined by medical history, Type 1 diabetes, dialysis.
  • History of active cancer in the past 3 years except for squamous or basal cell carcinomas of the skin that have been medically managed by local excision.
  • Unstable dietary history as defined by major changes in diet during the previous month, where the subject has eliminated or significantly increased a major food group in the diet.
  • Recent history of chronic excessive alcohol consumption defined as more than five 1.5-ounce servings of 80 proof distilled spirits, five 12-ounce servings of beer or five 5-ounce servings of wine per day; or > 14 drinks/week.
  • Any confirmed or suspected condition/state of immunosuppression or immunodeficiency (primary or acquired) including HIV infection, multiple sclerosis and Graves' disease.
  • Regular/frequent use of smoking or chewing tobacco, e-cigarettes, cigars or other nicotine-containing products.
  • Regular use of prescription opiate pain medication

结局指标

主要结局

Trimethylamine N-oxide (TMAO).

时间窗: Baseline and 8 weeks

Change from baseline in TMAO at 8 weeks.

次要结局

  • Weight(Baseline and 8 weeks)
  • Microbiota composition(Baseline and 8 weeks)
  • LDL Cholesterol(Baseline and 8 weeks)
  • Fasting glucose(Baseline and 8 weeks)
  • Fasting insulin(Baseline and 8 weeks)
  • Total Cholesterol(Baseline and 8 weeks)
  • Blood pressure(Baseline and 8 weeks)
  • HDL Cholesterol(Baseline and 8 weeks)
  • Waist circumference(Baseline and 8 weeks)
  • Insulin-like Growth Factor-1 (IGF-1)(Baseline and 8 weeks)
  • Microbiota function(Baseline and 8 weeks)
  • Triglycerides(Baseline and 8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christopher Gardner

Professor of Medicine

Stanford University

研究点 (2)

Loading locations...

相似试验